U.S., Nov. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07250724) titled 'C. Difficile Toxin Levels in Stool From Healthy Individuals Following Standard of Care Antibiotic Treatment for CDI.' on Sept. 26.
Brief Summary: Hospitals and clinics interested in participating in this multi-site study, please contact the people mentioned under "Contacts and Locations".
The goal of this study is to map the risk of having a C. Difficile infection recurrence (rCDI) after being treated with standard-of-care antibiotics for a C. Difficile infection.
The main questions it aims to answer are:
* What is the recurrence rate of CDI in the 8 weeks following antibiotic treatment for a first recurrence of CDI?
* Does toxi...